Raydiant Oximetry
Fred Ginnebaugh, MBA, is a seasoned executive with extensive experience in sales, marketing, and corporate strategy within the medical technology sector. Currently serving as the Sr. Director of Sales, Marketing, and Strategy at Earlens Corporation since October 2020, Fred also holds positions as an Executive in Residence at KCK Group and as an investor in several healthcare startups, including Raydiant Oximetry, Mindbloom, CivilGrid, and HealthPersonas. Prior experience includes roles such as Executive Client Director at GE Healthcare, where Fred succeeded in managing strategic relationships with major health systems, and Senior Cardiothoracic Territory Manager at Getinge North America. Fred's educational background includes an MBA from The Wharton School, an MS in Mechanical Engineering from the University of California, Berkeley, and a BS in Mechanical Engineering from the University of Michigan.
This person is not in the org chart
This person is not in any teams
Raydiant Oximetry
Raydiant Oximetry is a company dedicated to the mission of keeping mothers and babies safe during childbirth. They are developing a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood.